|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.16 USD | 0.00% |
|
0.00% | +11.70% |
| 07-28 | US FDA staff cast doubt on Replimune cancer drug's benefit; shares slide | RE |
| 07-28 | Medincell continues to strengthen its board of directors |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BMY Stock
- BMYUS Stock
- Consensus Bristol-Myers Squibb Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
